BB Biotech AG deal

Swiss biotech fund BB Biotech rejected an offer from Swiss bank Vontobel Group to take it private. Vontobel said the offer is a 31.7% premium to the CHF81.95 BB Biotech share price on July 12, the day before the offer was disclosed, which would put the offer price at about CHF107.93 per share, or a total of CHF1.4 billion ($1.4 billion) based on 13 million shares outstanding. ...